Clinical Oncology Next Generation Sequencing (NGS) Market Report

Global and Region Clinical Oncology Next Generation Sequencing (NGS) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：205
  • REPORT CODE：GMM944201
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Clinical Oncology Next Generation Sequencing (NGS) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Clinical Oncology Next Generation Sequencing (NGS)market, defines the market attractiveness level of Clinical Oncology Next Generation Sequencing (NGS) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Clinical Oncology Next Generation Sequencing (NGS) industry, describes the types of Clinical Oncology Next Generation Sequencing (NGS) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Clinical Oncology Next Generation Sequencing (NGS) market and the development prospects and opportunities of Clinical Oncology Next Generation Sequencing (NGS) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Clinical Oncology Next Generation Sequencing (NGS) market in Chapter 13.

    By Player:

    • CLC Bio

    • Roche

    • DNASTAR

    • Oxford Nanopore Technologies

    • Perkin Elmer

    • Pacific Bioscience

    • Paradigm

    • Partek

    • Agilent Technologies

    • Caris Life Sciences

    • Qiagen

    • Foundation Medicine

    • Biomatters

    • Illumina

    • Knome

    • Genomatix Software

    • Myriad Genetics

    • BGI

    • GATC Biotech

    • Exosome Diagnostics

    • GnuBIO

    • Life Technologies

    • Macrogen

    By Type:

    • NGS Pre-Sequencing

    • Sequencing

    • NGS Data Analysis

    • Primary, Secondary & Tertiary Data Analysis

    By End-User:

    • Academic & Clinical Research

    • Hospitals & Clinics

    • Pharma & Biotech Entities

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Clinical Oncology Next Generation Sequencing (NGS) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Clinical Oncology Next Generation Sequencing (NGS) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Clinical Oncology Next Generation Sequencing (NGS) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Clinical Oncology Next Generation Sequencing (NGS) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Clinical Oncology Next Generation Sequencing (NGS) Market Analysis and Outlook to 2022

    • 7.1 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    • 7.2 United States Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    • 7.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    • 7.4 China Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    • 7.5 Japan Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    • 7.6 India Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    • 7.7 South Korea Clinical Oncology Next Generation Sequencing (NGS) Consumption (2017-2022)

    8 Region and Country-wise Clinical Oncology Next Generation Sequencing (NGS) Market Analysis and Outlook to 2028

    • 8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    • 8.2 United States Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    • 8.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    • 8.4 China Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    • 8.5 Japan Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    • 8.6 India Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    • 8.7 South Korea Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast (2022-2028)

    9 Global Clinical Oncology Next Generation Sequencing (NGS) Market Outlook by Types and Applications to 2022

    • 9.1 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global NGS Pre-Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global NGS Data Analysis Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Primary, Secondary & Tertiary Data Analysis Consumption and Growth Rate (2017-2022)

    • 9.2 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Academic & Clinical Research Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharma & Biotech Entities Consumption and Growth Rate (2017-2022)

    10 Global Clinical Oncology Next Generation Sequencing (NGS) Market Outlook by Types and Applications to 2028

    • 10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global NGS Pre-Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global NGS Data Analysis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Primary, Secondary & Tertiary Data Analysis Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Academic & Clinical Research Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Pharma & Biotech Entities Consumption Forecast and Growth Rate (2022-2028)

    11 Global Clinical Oncology Next Generation Sequencing (NGS) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Clinical Oncology Next Generation Sequencing (NGS) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Analysis

    • 14.1 CLC Bio

      • 14.1.1 CLC Bio Company Details

      • 14.1.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.3 DNASTAR

      • 14.3.1 DNASTAR Company Details

      • 14.3.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.4 Oxford Nanopore Technologies

      • 14.4.1 Oxford Nanopore Technologies Company Details

      • 14.4.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.5 Perkin Elmer

      • 14.5.1 Perkin Elmer Company Details

      • 14.5.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.6 Pacific Bioscience

      • 14.6.1 Pacific Bioscience Company Details

      • 14.6.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.7 Paradigm

      • 14.7.1 Paradigm Company Details

      • 14.7.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.8 Partek

      • 14.8.1 Partek Company Details

      • 14.8.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.9 Agilent Technologies

      • 14.9.1 Agilent Technologies Company Details

      • 14.9.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.10 Caris Life Sciences

      • 14.10.1 Caris Life Sciences Company Details

      • 14.10.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.11 Qiagen

      • 14.11.1 Qiagen Company Details

      • 14.11.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.12 Foundation Medicine

      • 14.12.1 Foundation Medicine Company Details

      • 14.12.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.13 Biomatters

      • 14.13.1 Biomatters Company Details

      • 14.13.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.14 Illumina

      • 14.14.1 Illumina Company Details

      • 14.14.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.15 Knome

      • 14.15.1 Knome Company Details

      • 14.15.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.16 Genomatix Software

      • 14.16.1 Genomatix Software Company Details

      • 14.16.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.17 Myriad Genetics

      • 14.17.1 Myriad Genetics Company Details

      • 14.17.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.18 BGI

      • 14.18.1 BGI Company Details

      • 14.18.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.19 GATC Biotech

      • 14.19.1 GATC Biotech Company Details

      • 14.19.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.20 Exosome Diagnostics

      • 14.20.1 Exosome Diagnostics Company Details

      • 14.20.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.21 GnuBIO

      • 14.21.1 GnuBIO Company Details

      • 14.21.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.22 Life Technologies

      • 14.22.1 Life Technologies Company Details

      • 14.22.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • 14.23 Macrogen

      • 14.23.1 Macrogen Company Details

      • 14.23.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Clinical Oncology Next Generation Sequencing (NGS)

    • Figure Clinical Oncology Next Generation Sequencing (NGS) Picture

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Consumption by Country (2017-2022)

    • Figure United States Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Table Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Figure India Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Clinical Oncology Next Generation Sequencing (NGS) Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast by Country (2022-2028)

    • Figure United States Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NGS Pre-Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global NGS Data Analysis Consumption and Growth Rate (2017-2022)

    • Figure Global Primary, Secondary & Tertiary Data Analysis Consumption and Growth Rate (2017-2022)

    • Figure Global Academic & Clinical Research Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Pharma & Biotech Entities Consumption and Growth Rate (2017-2022)

    • Figure Global NGS Pre-Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NGS Data Analysis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Primary, Secondary & Tertiary Data Analysis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic & Clinical Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharma & Biotech Entities Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Export by Region (Top 5 Countries) (2017-2028)

    • Table CLC Bio (Foundation Year, Company Profile and etc.)

    • Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table DNASTAR (Foundation Year, Company Profile and etc.)

    • Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Oxford Nanopore Technologies (Foundation Year, Company Profile and etc.)

    • Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Perkin Elmer (Foundation Year, Company Profile and etc.)

    • Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Pacific Bioscience (Foundation Year, Company Profile and etc.)

    • Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Paradigm (Foundation Year, Company Profile and etc.)

    • Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Partek (Foundation Year, Company Profile and etc.)

    • Table Partek Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Partek Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Agilent Technologies (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Caris Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Qiagen (Foundation Year, Company Profile and etc.)

    • Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Foundation Medicine (Foundation Year, Company Profile and etc.)

    • Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Biomatters (Foundation Year, Company Profile and etc.)

    • Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Knome (Foundation Year, Company Profile and etc.)

    • Table Knome Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Knome Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Genomatix Software (Foundation Year, Company Profile and etc.)

    • Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table BGI (Foundation Year, Company Profile and etc.)

    • Table BGI Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BGI Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table GATC Biotech (Foundation Year, Company Profile and etc.)

    • Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Exosome Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table GnuBIO (Foundation Year, Company Profile and etc.)

    • Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Life Technologies (Foundation Year, Company Profile and etc.)

    • Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product and Service

    • Table Macrogen (Foundation Year, Company Profile and etc.)

    • Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US